375 related articles for article (PubMed ID: 30834514)
21. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.
Fond G; Hamdani N; Kapczinski F; Boukouaci W; Drancourt N; Dargel A; Oliveira J; Le Guen E; Marlinge E; Tamouza R; Leboyer M
Acta Psychiatr Scand; 2014 Mar; 129(3):163-79. PubMed ID: 24215721
[TBL] [Abstract][Full Text] [Related]
23. Statins in the treatment of depression: Hype or hope?
Köhler-Forsberg O; Otte C; Gold SM; Østergaard SD
Pharmacol Ther; 2020 Nov; 215():107625. PubMed ID: 32652185
[TBL] [Abstract][Full Text] [Related]
24. The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Evans VC; Alamian G; McLeod J; Woo C; Yatham LN; Lam RW
CNS Drugs; 2016 May; 30(5):405-17. PubMed ID: 27113464
[TBL] [Abstract][Full Text] [Related]
25. Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials.
De Giorgi R; De Crescenzo F; Rizzo Pesci N; Martens M; Howard W; Cowen PJ; Harmer CJ
PLoS One; 2021; 16(3):e0249409. PubMed ID: 33784356
[TBL] [Abstract][Full Text] [Related]
26. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
27. Antidepressants plus benzodiazepines for adults with major depression.
Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
[TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo.
Fourrier C; Sampson E; Mills NT; Baune BT
Trials; 2018 Aug; 19(1):447. PubMed ID: 30126458
[TBL] [Abstract][Full Text] [Related]
29. Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.
Agabio R; Trogu E; Pani PP
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008581. PubMed ID: 29688573
[TBL] [Abstract][Full Text] [Related]
30. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials.
Eyding D; Lelgemann M; Grouven U; Härter M; Kromp M; Kaiser T; Kerekes MF; Gerken M; Wieseler B
BMJ; 2010 Oct; 341():c4737. PubMed ID: 20940209
[TBL] [Abstract][Full Text] [Related]
31. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
32. The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis.
Meeker AS; Herink MC; Haxby DG; Hartung DM
Syst Rev; 2015 Mar; 4():21. PubMed ID: 25874839
[TBL] [Abstract][Full Text] [Related]
33. Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis.
Rocha FL; Fuzikawa C; Riera R; Hara C
J Clin Psychopharmacol; 2012 Apr; 32(2):278-81. PubMed ID: 22367652
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis.
Zhou X; Cipriani A; Furukawa TA; Cuijpers P; Zhang Y; Hetrick SE; Pu J; Yuan S; Del Giovane C; Xie P
BMJ Open; 2018 Jan; 8(1):e018357. PubMed ID: 29306886
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of St. John's wort for major depressive disorder.
Apaydin EA; Maher AR; Shanman R; Booth MS; Miles JN; Sorbero ME; Hempel S
Syst Rev; 2016 Sep; 5(1):148. PubMed ID: 27589952
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Papakostas GI; Homberger CH; Fava M
J Psychopharmacol; 2008 Nov; 22(8):843-8. PubMed ID: 18308801
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological treatment for psychotic depression.
Wijkstra J; Lijmer J; Burger H; Cipriani A; Geddes J; Nolen WA
Cochrane Database Syst Rev; 2015 Jul; (7):CD004044. PubMed ID: 26225902
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological treatment for psychotic depression.
Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
[TBL] [Abstract][Full Text] [Related]
39. Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
Fernandes BM; Scotti-Muzzi E; Soeiro-de-Souza MG
Eur J Clin Pharmacol; 2022 Mar; 78(3):339-349. PubMed ID: 34708271
[TBL] [Abstract][Full Text] [Related]
40. Early and sustained improvement with vilazodone in adult patients with major depressive disorder: post hoc analyses of two phase III trials.
Jain R; Chen D; Edwards J; Mathews M
Curr Med Res Opin; 2014 Feb; 30(2):263-70. PubMed ID: 24127687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
